Senzime AB (publ) Stock Nasdaq Stockholm
Equities
SE0002478776
Medical Equipment, Supplies & Distribution
Sales 2024 * | 74M 7.05M 9.61M | Sales 2025 * | 180M 17.15M 23.37M | Capitalization | 904M 86.12M 117M |
---|---|---|---|---|---|
Net income 2024 * | -103M -9.81M -13.37M | Net income 2025 * | -40M -3.81M -5.19M | EV / Sales 2024 * | 11.7 x |
Net cash position 2024 * | 36M 3.43M 4.67M | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 5.02 x |
P/E ratio 2024 * |
-8.78
x | P/E ratio 2025 * |
-22.9
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 53.5% |
Latest transcript on Senzime AB (publ)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 15-12-31 | |
Director of Finance/CFO | 54 | 21-12-31 | |
Fredrik Norrby
CTO | Chief Tech/Sci/R&D Officer | 48 | 19-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 15-12-31 | |
Director/Board Member | 72 | 22-12-31 | |
Director/Board Member | 51 | 99-12-31 |
1st Jan change | Capi. | |
---|---|---|
-7.03% | 180B | |
-6.32% | 99.21B | |
-6.15% | 66.25B | |
-10.62% | 44.74B | |
+8.34% | 43.82B | |
+10.35% | 41.96B | |
+11.64% | 28.98B | |
+16.18% | 24.07B | |
-8.87% | 23.5B |